182 related articles for article (PubMed ID: 25490200)
1. Early inflammatory markers are independent predictors of cardiac allograft vasculopathy in heart-transplant recipients.
Labarrere CA; Woods JR; Hardin JW; Jaeger BR; Zembala M; Deng MC; Kassab GS
PLoS One; 2014; 9(12):e113260. PubMed ID: 25490200
[TBL] [Abstract][Full Text] [Related]
2. Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation.
Arora S; Gullestad L; Wergeland R; Simonsen S; Holm T; Hognestad A; Ueland T; Geiran O; Andreassen A
Transplantation; 2007 May; 83(10):1308-15. PubMed ID: 17519779
[TBL] [Abstract][Full Text] [Related]
3. Interplay between systemic inflammation and markers of insulin resistance in cardiovascular prognosis after heart transplantation.
Biadi O; Potena L; Fearon WF; Luikart HI; Yeung A; Ferrara R; Hunt SA; Mocarski ES; Valantine HA
J Heart Lung Transplant; 2007 Apr; 26(4):324-30. PubMed ID: 17403472
[TBL] [Abstract][Full Text] [Related]
4. Value of the first post-transplant biopsy for predicting long-term cardiac allograft vasculopathy (CAV) and graft failure in heart transplant patients.
Labarrere CA; Woods JR; Hardin JW; Campana GL; Ortiz MA; Jaeger BR; Baldridge LA; Pitts DE; Kirlin PC
PLoS One; 2012; 7(4):e36100. PubMed ID: 22558345
[TBL] [Abstract][Full Text] [Related]
5. Follow-up study on the utility of von Willebrand factor levels in the diagnosis of cardiac allograft vasculopathy.
Martínez-Dolz L; Almenar L; Reganon E; Vila V; Chamorro C; Andrés L; Martínez-Sales V; Moro J; Agüero J; Sánchez-Lázaro I; Salvador A
J Heart Lung Transplant; 2008 Jul; 27(7):760-6. PubMed ID: 18582806
[TBL] [Abstract][Full Text] [Related]
6. Systemic inflammation and metabolic syndrome in cardiac allograft vasculopathy.
Raichlin ER; McConnell JP; Lerman A; Kremers WK; Edwards BS; Kushwaha SS; Clavell AL; Rodeheffer RJ; Frantz RP
J Heart Lung Transplant; 2007 Aug; 26(8):826-33. PubMed ID: 17692787
[TBL] [Abstract][Full Text] [Related]
7. Computational Analysis of Routine Biopsies Improves Diagnosis and Prediction of Cardiac Allograft Vasculopathy.
Peyster EG; Janowczyk A; Swamidoss A; Kethireddy S; Feldman MD; Margulies KB
Circulation; 2022 May; 145(21):1563-1577. PubMed ID: 35405081
[TBL] [Abstract][Full Text] [Related]
8. Elevated uric acid levels predict allograft vasculopathy in cardiac transplant recipients.
Kittleson MM; Bead V; Fradley M; St John ME; Champion HC; Kasper EK; Russell SD; Wittstein IS; Hare JM
J Heart Lung Transplant; 2007 May; 26(5):498-503. PubMed ID: 17449420
[TBL] [Abstract][Full Text] [Related]
9. Impaired cholesterol efflux capacity and vasculoprotective function of high-density lipoprotein in heart transplant recipients.
Singh N; Jacobs F; Rader DJ; Vanhaecke J; Van Cleemput J; De Geest B
J Heart Lung Transplant; 2014 May; 33(5):499-506. PubMed ID: 24630408
[TBL] [Abstract][Full Text] [Related]
10. Plasma C-reactive protein as a marker of cardiac allograft vasculopathy in heart transplant recipients.
Hognestad A; Endresen K; Wergeland R; Stokke O; Geiran O; Holm T; Simonsen S; Kjekshus JK; Andreassen AK
J Am Coll Cardiol; 2003 Aug; 42(3):477-82. PubMed ID: 12906976
[TBL] [Abstract][Full Text] [Related]
11. Early prediction of cardiac allograft vasculopathy and heart transplant failure.
Labarrere CA; Woods JR; Hardin JW; Campana GL; Ortiz MA; Jaeger BR; Reichart B; Bonnin JM; Currin A; Cosgrove S; Pitts DE; Kirlin PC; O'Donnell JA; Hormuth DA; Wozniak TC
Am J Transplant; 2011 Mar; 11(3):528-35. PubMed ID: 21219580
[TBL] [Abstract][Full Text] [Related]
12. What is the best biomarker for diagnosis of rejection in heart transplantation?
Martínez-Dolz L; Almenar L; Reganon E; Vila V; Sánchez-Soriano R; Martínez-Sales V; Moro J; Agüero J; Sánchez-Lázaro I; Salvador A
Clin Transplant; 2009; 23(5):672-80. PubMed ID: 19712083
[TBL] [Abstract][Full Text] [Related]
13. Immune function surveillance: association with rejection, infection and cardiac allograft vasculopathy.
Heikal NM; Bader FM; Martins TB; Pavlov IY; Wilson AR; Barakat M; Stehlik J; Kfoury AG; Gilbert EM; Delgado JC; Hill HR
Transplant Proc; 2013; 45(1):376-82. PubMed ID: 23267802
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory response and re-stenosis after percutaneous coronary intervention in heart transplant recipients and patients with native atherosclerosis.
Hognestad A; Endresen K; Wergeland R; Mellembakken JR; Mollnes TE; Omland T; Kjekshus JK; Aukrust P; Andreassen AK
J Heart Lung Transplant; 2005 Aug; 24(8):1026-32. PubMed ID: 16102437
[TBL] [Abstract][Full Text] [Related]
15. Blood glutathione as a marker of cardiac allograft vasculopathy in heart transplant recipients.
De Chiara B; Bigi R; Campolo J; Parolini M; Turazza F; Masciocco G; Frigerio M; Fiorentini C; Parodi O
Clin Transplant; 2005 Jun; 19(3):367-71. PubMed ID: 15877800
[TBL] [Abstract][Full Text] [Related]
16. CD4+CD45RO+CD25-/lowCD127+: CD4+CD45RO+CD25hiCD127-/low Ratio in Peripheral Blood: A Useful Biomarker to Detect Cardiac Allograft Vasculopathy in Heart Transplanted Patients.
Roldán C; Mirabet S; Cecilia C; Brossa V; Roig E; Martín C; Gelpí C
Transplantation; 2015 Jul; 99(7):1521-8. PubMed ID: 25539460
[TBL] [Abstract][Full Text] [Related]
17. [Association between serum NT-proBNP/hs-CRP and acute rejection after heart transplantation].
Yin D; Huang J; Feng L; Feng GX; Hu SS
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Feb; 37(2):145-8. PubMed ID: 19719993
[TBL] [Abstract][Full Text] [Related]
18. Influence of traditional cardiovascular risk factors in the recipient on the development of cardiac allograft vasculopathy after heart transplantation.
Sánchez Lázaro IJ; Almenar Bonet L; Moro López J; Sánchez Lacuesta E; Martínez-Dolz L; Agüero Ramón-Llín J; Andrés Lalaguna L; Cano Pérez O; Ortiz Martínez V; Buendía Fuentes F; Salvador Sanz A
Transplant Proc; 2008 Nov; 40(9):3056-7. PubMed ID: 19010192
[TBL] [Abstract][Full Text] [Related]
19. Genetic and Functional Profiling of CD16-Dependent Natural Killer Activation Identifies Patients at Higher Risk of Cardiac Allograft Vasculopathy.
Paul P; Picard C; Sampol E; Lyonnet L; Di Cristofaro J; Paul-Delvaux L; Lano G; Nicolino-Brunet C; Ravis E; Collart F; Dignat-George F; Dussol B; Sabatier F; Mouly-Bandini A
Circulation; 2018 Mar; 137(10):1049-1059. PubMed ID: 29097449
[TBL] [Abstract][Full Text] [Related]
20. Assessment of immunological markers as mediators of graft vasculopathy development in heart transplantation.
Mirabet S; Gelpí C; Roldán C; Brossa V; Mendoza CA; Lopez L; Molto E; Alvaro Y; Martinez V; Padró JM; Roig E
Transplant Proc; 2011; 43(6):2253-6. PubMed ID: 21839249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
